Interleukin-1 Blockade in Heart Failure With Preserved Ejection Fraction (HFpEF): a Randomized Placebo-controlled Double Blinded Study (D-HART2)
Phase of Trial: Phase II
Latest Information Update: 23 Aug 2016
At a glance
- Drugs Anakinra (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- Acronyms D-HART2
- 07 Jun 2017 Biomarkers information updated
- 17 Aug 2016 Planned End Date changed from 1 Sep 2016 to 1 Sep 2017.
- 17 Aug 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Jul 2017.